3D Cell Cultures Technologies and Global Markets: Revenue Data for 2020-2022 with Compound Annual Growth Rates (CAGRs) Projections Spanning through 2028
19 Feb 2024
Cell Therapy
DUBLIN, Feb. 19, 2024 /PRNewswire/ -- The '3D Cell Cultures: Technologies and Global Markets' report has been added to
ResearchAndMarkets.com's offering.
3D cell culture technologies are a powerful tool for studying cell biology, disease mechanisms and drug discovery. 3D cell culture models mimic the 3D structure and cell-cell interactions that are found in real tissues, making them more accurate and predictive than traditional 2D cell culture models.
There are a variety of 3D cell culture technologies available, including:
Scaffold-based 3D cell culture: This approach uses a scaffold to provide a 3D support structure for cells to grow on. Scaffolds can be made from a variety of materials, including natural polymers, synthetic polymers and hydrogels.
Scaffold-free 3D cell culture: This approach does not use a scaffold. Instead, cells are grown in a suspension of culture medium and gel-forming agents, such as collagen or Matrigel.
Bioprinting: This approach uses a 3D printer to deposit cells and biomaterials layer-by-layer to create complex 3D cell culture models.
3D cell culture technologies have a wide range of applications, including:
Drug discovery: 3D cell culture models can be used to screen new drug candidates for safety and efficacy before they are tested in clinical trials. 3D cell culture models can also be used to study the mechanisms of drug resistance and to develop new strategies to overcome drug resistance.
Disease modeling: 3D cell culture models can be used to study the biology of diseases and to develop new treatments. For example, 3D cancer models can be used to study tumor growth and metastasis, and 3D neurodegenerative disease models can be used to study the progression of neurodegenerative diseases.
Regenerative medicine: 3D cell culture models can be used to develop new cell-based therapies for a variety of diseases. For example, 3D skin models can be used to grow new skin for patients with burns or other skin injuries, and 3D liver models can be used to grow new liver tissue for patients with liver disease.
This report aims to provide a comprehensive study of the global 3D cell culture technologies market. It provides a detailed description of the different types of healthcare interoperability solutions and their current and historical market revenues.
The scope of the report encompasses the major types of 3D cell culture which are being used by industry, academic researchers, government labs, and independent research groups. This includes the main inputs such as cell lines, media, sera, reagents, software, and instrumentation. It analyzes the current market status, examines future market drivers and presents forecasts of growth over the next five years.
The market structure has been reorganized for this edition. Also, more research was done on base case data for different product areas. The greater emphasis is on the different products used for 3D cell culture, but the report also investigates the market in terms of types of applications, end users and geographic regions.
The Report Includes
17 data tables and 105 additional tables
An overview of the global market landscape related to the 3D cell cultures technologies
In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
Evaluation of the current market size and revenue growth prospects specific to 3D cell cultures technologies, accompanied by a comprehensive market share analysis categorized by type, end user, and geographical region
Information on analytical systems used in tissue and cell culture, cellomics, and human cancer model initiative (HCMI)
Details about assay development for mesenchymal stem cells, In Vitro testing of adventitious agents and description of assays and assay kits
Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities and discussion on the impact of COVID-19 on the world of cell culture
Insights into U.S. regulatory status of bioprinted products; basic guidance for the regulation of biologics, regenerative medicine and xenotransplants
Relevant patent analysis, including recent activity and a list of key patents
Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses, including Abcam PLC, Agilent Technologies Inc., Corning Inc., Merck KGAA, Beckman Coulter, and Synvivo Inc.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
Chapter 4 Market, by Type
Chapter 5 Assays, Imaging and Analysis
Chapter 6 Regulation and Standardization
Chapter 7 3D Models for Cancer
Chapter 8 Landscape for Toxicology and Drug Safety Testing
Chapter 9 Market Breakdown by Region
Chapter 10 Stem Cell Landscape
Chapter 11 Regenerative Medicine: Organ Transplants and Skin Substitutes
Chapter 12 Company Profiles
4D Technology
Bioinspired Solutions
Cell Applications
Cellink
Corning
Cytiva
Cytoo
EMD Millipore / Merck
Emulate
Eurofins
Hub Organoids
Insphero
Invitrocue
Mattek
Mimetas
Perkinelmer
Plasticell
Poietis
For more information about this report visit https://www.researchandmarkets.com/r/4sq066
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.